customer challenge

A United States-based biopharmaceutical company faced significant operational risks due to supply chain disruptions. The company relied on overseas suppliers for sodium hydroxide (NaOH) pellets, leading to long lead times and production delays. These challenges threatened the company's ability to meet production targets and regulatory compliance.

Aurorium's solution

Aurorium stepped in as a trusted partner, providing multiple grades of Haelium™ NaOH Pellets that met the customer's exacting requirements. By sourcing and manufacturing high-purity pharmaceutical-grade sodium hydroxide in the United States, Aurorium ensured a stable and reliable supply.

key features of Aurorium's solution included:

• Multi-Compendial Compliance: meeting the specifications required for:
  • ACS (American Chemical Society)
  • BP (British Pharmacopeia)
  • EP (European Pharmacopeia)
  • JP (Japanese Pharmacopoeia)
  • NF (National Foundry)
• cGMP Manufacturing: Ensuring quality and consistency for biopharmaceutical applications.
• Reliable Supply Chain: Domestic manufacturing reduced lead times and mitigated supply chain risks.

proven benefits

• Supply Chain Resilience: shorter lead times and reduced dependency on overseas suppliers.
• Consistent Quality: guaranteed high-purity NaOH pellets for critical biopharmaceutical processes.
• Optimized Performance: supporting drug formulation and biocompatibility for enhanced therapeutic outcomes.

customer impact

With Aurorium's support, the biopharmaceutical manufacturer successfully stabilized its supply chain, eliminated production delays, and ensured uninterrupted manufacturing operations. This partnership enabled the company to maintain its competitive edge while meeting stringent industry regulations.

future outlook

Aurorium continues to innovate and support biopharmaceutical companies with cutting-edge chemical solutions, reinforcing our commitment to excellence in pharmaceutical-grade sodium hydroxide production.